You are right about it being a problem but things are changing and thus the opportunity. Calmare is now on the CRPS.org site. http://rsds.org/?s=scrambler+therapy One Calmare doctor got six CRPS referrals in one day. Calmare was featured in an article by The Foundation for Peripheral Neuropathy last month. https://www.foundationforpn.org/2016/12/09/scrambler-therapy-for-treating-neuropathic-pain/ Calmare was featured in The Mayo Clinic Health Letter Nov 11th. Did you notice sales go up !50% in the 3rd quarter? Two nuerologists have purchased Calmare recently. Big step up from chiropractors. The pain management industry is desperately trying to find a non-pharma solution to pain. Calmare should fill a big part of that void. We have a new president that is anti-drug when it comes to treating pain. It's already happening. Bells and Whistles don't go off before a big move in a stock. I expect 3 important studies to be out by February. Two are double-blind studies with a sham device, these have been ongoing 2 to 3 years. https://clinicaltrials.gov/ct2/show/NCT02701075?term=scrambler+therapy&rank=2 https://clinicaltrials.gov/ct2/show/NCT02111174?term=scrambler+therapy&rank=6 It's already happening! 2017 should be a break out year for Calmare.